Альманах клинической медицины. 2014; : 3-11
ОСОБЕННОСТИ НЕФРОПАТИЙ ПРИ ЛИМФОПРОЛИФЕРАТИВНЫХ И ПЛАЗМОКЛЕТОЧНЫХ ЗАБОЛЕВАНИЯХ (ОПЫТ ОДНОГО ЦЕНТРА)
https://doi.org/10.18786/2072-0505-2014-30-3-11Аннотация
Список литературы
1. Бирюкова Л.С., Тангиева Л.М., Тимохов B.C. и др. Комплексная терапия хронической почечной недостаточности у больных миеломной болезнью//Нефрол. и диализ. 2002. N92. С.98-105.
2. Бирюкова Л.С., Тимохов B.C. Нефрологические аспекты заболеваний системы крови//Тер. арх. 2003. №6. С.73-79.
3. Ромеев В.В., Козловская Л.В., Когарко И.И. Новые возможности диагностики и мониторирования AL-амилоидоза//Тер. арх. 2010. N96. С.29-31.
4. Рехтина И.Г., Голицина Е.П., Варламова Е.Ю. и др. Морфологические и иммунохимические особенности нефропатий при множественной миеломе с тяжелой почечной недостаточностью//Тер. арх. 2013. №3. С.80-85.
5. Cambier J.F., Ronco P. Onco-nephrology: glomerular diseases with cancer//Clin. J. Am. Soc. Nephrol. 2012. V.7, No.10. P.1701-1712.
6. Cohen A.H. The kidney in plasma cell dyscrasias: Bence-Jones cast nephropathy and light chain deposition disease//Am. J. Kidney Dis. 1998. V.32. P.529-532.
7. Da'as N., Polliack A., Cohen Y. et al. Kidney involvement and renal manifestations in non-Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients//Eur. J. Haematol. 2001. V.67. P.158-160.
8. Magier K.T., Lynch J.W. Jr. Paraneoplastic manifestations of lymphoma//Clin. Lymphoma. 2004. V.5, No.l. P.29-36.
9. Heher E.C., Goes N.B., Spitzer T.R. et al. Kidney disease associated with plasma cell dyscrasias//Blood. 2010. V.116. P.1397-1404.
10. Herrera G.A., Joseph L., Gu X. et al. Renal pathological spectrum in an autopsy series of patients with plasma cell dyscrasia//Arch. Path. Lab. Med. 2004. V.128. P.875-879.
11. Keeling J., Teng J., Herrera G.A. AL-amyloidosis and light-chain deposition disease: light chains induce divergent phenotypic transformations of human mesangial cells//Lab. Invest. 2004. V.84, No.10. P.1322-1338.
12. Korbet S.M., Schwartz M.M. Multiple myeloma//J. Am. Soc. Nephrol. 2006. V.17. P.2533-2545.
13. Leung N., Bridoux F., Hutchinson С.A. et al. Monoclonal gammopathy of renal significance (MGRS): when MGUS is no longer undetermined or insignificant//Blood. 2012. V.120, No.22. P.4292-4295.
14. Leung N., Dispenzieri A., Fervenza F.C. et al. Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis//Am. J. Kidney Dis. 2005. V.46, No.2. P.270-277.
15. Nasr S.H., Markowitz G.S., Stokes M.B. et al. Proliferative glomerulonephritis with monoclonal IgG deposits; a distinct entity mimicking immune-complex glomerulonephritis//Kidney Int. 2004. V.65. P.85-96.
16. Ronco P.M. Paraneoplastic glomerulopathies: new insights into an old entity 11 Kidney Int. 1999. V.56. P.355-377.
17. Ronco P., Plaisier E., Aucouturier P. Ig-related renal disease in lymphoplasmacytic disorders: An update//Semin. Nephrol. 2010. V.30. P.557-569.
18. Royer B., Arnulf В., Martinez F. et al. High dose chemotherapy in light chain or light and heavy chain deposition disease//Kidney Int. 2004. V.65. P.642-648.
19. Sanders P.W., Booker B.B. Pathobiology of cast nephropathy from human Bence-Jones proteins//J. Clin. Invest. 1992. V.89. P.630-639.
20. Weichman К., Dember L.M., Prokaeva T. at el. Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high dose melphalan and autologous stem cell transplantation//Bone Marrow Transplantation. 2006. V.38. P.339-346.
Almanac of Clinical Medicine. 2014; : 3-11
KIDNEY DAMAGE IN LYMPHOPROLIFERATIVE AND PLASMA CELL DISORDERS (ONE CENTER EXPERIENCE)
https://doi.org/10.18786/2072-0505-2014-30-3-11Abstract
References
1. Biryukova L.S., Tangieva L.M., Timokhov B.C. i dr. Kompleksnaya terapiya khronicheskoi pochechnoi nedostatochnosti u bol'nykh mielomnoi bolezn'yu//Nefrol. i dializ. 2002. N92. S.98-105.
2. Biryukova L.S., Timokhov B.C. Nefrologicheskie aspekty zabolevanii sistemy krovi//Ter. arkh. 2003. №6. S.73-79.
3. Romeev V.V., Kozlovskaya L.V., Kogarko I.I. Novye vozmozhnosti diagnostiki i monitorirovaniya AL-amiloidoza//Ter. arkh. 2010. N96. S.29-31.
4. Rekhtina I.G., Golitsina E.P., Varlamova E.Yu. i dr. Morfologicheskie i immunokhimicheskie osobennosti nefropatii pri mnozhestvennoi mielome s tyazheloi pochechnoi nedostatochnost'yu//Ter. arkh. 2013. №3. S.80-85.
5. Cambier J.F., Ronco P. Onco-nephrology: glomerular diseases with cancer//Clin. J. Am. Soc. Nephrol. 2012. V.7, No.10. P.1701-1712.
6. Cohen A.H. The kidney in plasma cell dyscrasias: Bence-Jones cast nephropathy and light chain deposition disease//Am. J. Kidney Dis. 1998. V.32. P.529-532.
7. Da'as N., Polliack A., Cohen Y. et al. Kidney involvement and renal manifestations in non-Hodgkin's lymphoma and lymphocytic leukemia: a retrospective study in 700 patients//Eur. J. Haematol. 2001. V.67. P.158-160.
8. Magier K.T., Lynch J.W. Jr. Paraneoplastic manifestations of lymphoma//Clin. Lymphoma. 2004. V.5, No.l. P.29-36.
9. Heher E.C., Goes N.B., Spitzer T.R. et al. Kidney disease associated with plasma cell dyscrasias//Blood. 2010. V.116. P.1397-1404.
10. Herrera G.A., Joseph L., Gu X. et al. Renal pathological spectrum in an autopsy series of patients with plasma cell dyscrasia//Arch. Path. Lab. Med. 2004. V.128. P.875-879.
11. Keeling J., Teng J., Herrera G.A. AL-amyloidosis and light-chain deposition disease: light chains induce divergent phenotypic transformations of human mesangial cells//Lab. Invest. 2004. V.84, No.10. P.1322-1338.
12. Korbet S.M., Schwartz M.M. Multiple myeloma//J. Am. Soc. Nephrol. 2006. V.17. P.2533-2545.
13. Leung N., Bridoux F., Hutchinson S.A. et al. Monoclonal gammopathy of renal significance (MGRS): when MGUS is no longer undetermined or insignificant//Blood. 2012. V.120, No.22. P.4292-4295.
14. Leung N., Dispenzieri A., Fervenza F.C. et al. Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis//Am. J. Kidney Dis. 2005. V.46, No.2. P.270-277.
15. Nasr S.H., Markowitz G.S., Stokes M.B. et al. Proliferative glomerulonephritis with monoclonal IgG deposits; a distinct entity mimicking immune-complex glomerulonephritis//Kidney Int. 2004. V.65. P.85-96.
16. Ronco P.M. Paraneoplastic glomerulopathies: new insights into an old entity 11 Kidney Int. 1999. V.56. P.355-377.
17. Ronco P., Plaisier E., Aucouturier P. Ig-related renal disease in lymphoplasmacytic disorders: An update//Semin. Nephrol. 2010. V.30. P.557-569.
18. Royer B., Arnulf V., Martinez F. et al. High dose chemotherapy in light chain or light and heavy chain deposition disease//Kidney Int. 2004. V.65. P.642-648.
19. Sanders P.W., Booker B.B. Pathobiology of cast nephropathy from human Bence-Jones proteins//J. Clin. Invest. 1992. V.89. P.630-639.
20. Weichman K., Dember L.M., Prokaeva T. at el. Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high dose melphalan and autologous stem cell transplantation//Bone Marrow Transplantation. 2006. V.38. P.339-346.
